Skip to content
healthcare.dev

Lamivudine and Zidovudine

NDC 71335-1916, Lamivudine and Zidovudine, tablet, from Bryant Ranch Prepack.

Product NDC
71335-1916
Status
Listed
Labeler
Bryant Ranch Prepack
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090679
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1916 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE150 mg/1
  • ZIDOVUDINE300 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
71335-1916-1713351916016 TABLET in 1 BOTTLE (71335-1916-1)
71335-1916-27133519160260 TABLET in 1 BOTTLE (71335-1916-2)
71335-1916-3713351916034 TABLET in 1 BOTTLE (71335-1916-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/61d14a88-9fdf-4373-8360-44ec9e1cd350

Use it

Look up 71335-1916 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71335-1916 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71335-1916. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.